CD4 and neoplasm: The results uncovered more activated memory CD4+ T cells, M1 macrophages (anti-tumor phenotype), and CD8+ T cells in low-CDIGPM group, but more M2 macrophages (pro-tumor phenotype) in high-CDIGPM group (Figures 5A, B).